Enhanced Drug Access to Eye Tissues

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$232,945.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43EY015606-01
Agency Tracking Number:
EY015606
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
NACELLE THERAPEUTICS, INC.
NACELLE THERAPEUTICS, INC., 1500 HAYES DR, MANHATTAN, KS, 66502
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
JOHN Tomich
(785) 532-3900
JTOMICH@KSU.EDU
Business Contact:
GARY RABOLD
(785) 532-3906
GRABOLD@KSU.EDU
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant) The innovative use of a synthetic peptide to modulate epithelial cell-cell interactions is proposed for the augmentation of drug- or gene-based therapeutic interventions. Cell monolayers are a major obstacle to deli

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government